Iron stores and HFE genotypes are not related to increased risk of ischemic stroke: A prospective nested case-referent study

Cerebrovascular Diseases

Volumn 24, Issue 5, 2007, Pages 405-411

  Ekblom, Kim ^a   Hultdin, Johan ^a   Stegmayr, Birgitta ^a   Johansson, Ingegerd ^a   Van Guelpen, Bethany ^a   Hallmans, Göran ^a   Weinehall, Lars ^a   Johansson, Lars ^b   Wiklund, Per Gunnar ^a   Marklund, Stefan L ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Skelleftea Hospital   (Sweden)

Author keywords

Cerebral infarct; Ferritin; HFE genotypes; Intracerebral hemorrhage; Iron

Indexed keywords

FERRITIN; HFE PROTEIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SWEDEN;

ADULT; AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; FEMALE; FERRITINS; GENETIC PREDISPOSITION TO DISEASE; HEALTH SURVEYS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; IRON-BINDING PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE; SWEDEN; TRANSFERRIN;

EID: 35548944977     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108429     Document Type: Article

References (24)

1. Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:20963-20966.
2. Wardman P, Candeias LP: Fenton chemistry: an introduction. Radiat Res 1996;145:523-531.
3. Sullivan JL: Iron and the sex difference in heart disease risk. Lancet 1981;i:1293-1294.
4. Danesh J, Appleby P: Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999;99:852-854.
5. Salonen JT, Tuomainen TP, Salonen R, Lakka TA, Nyyssonen K: Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol 1998;148:445-451.
6. Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF: Possible association of a reduction in cardiovascular events with blood donation. Heart 1997;78:188-193.
7. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ: Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52-57.
8. van der AD, Grobbee DE, Roest M, Marx JJ, Voorbij HA, van der Schouw YT: Serum ferritin is a risk factor for stroke in postmenopausal women. Stroke 2005;36:1637-1641.
9. Marniemi J, Alanen E, Impivaara O, Seppanen R, Hakala P, Rajala T, Ronnemaa T: Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005;15:188-197.
10. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F: Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300-3307.
11. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P: Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-1778.
12. Hruskovicova H, Milanez T, Kobal J, Potisk KP, Petrovic D, Peterlin B: Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction. Med Sci Monit 2005;11:BR248-BR252.
13. Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, Sixma JJ, Banga JD: Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999;100:1268-1273.
14. Njajou OT, Hollander M, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM, van Duijn CM: Mutations in the hemochromatosis gene (HFE) and stroke. Stroke 2002;33:2363-2366.
15. Stegmayr B, Lundberg V, Asplund K: The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health Suppl 2003;61:9-17.
16. Weinehall L, Hallgren CG, Westman G, Janlert U, Wall S: Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care 1998;16:171-176.
17. Johansson L, Jansson JH, Stegmayr B, Nilsson TK, Hallmans G, Boman K: Hemostatic factors as risk markers for intracerebral hemorrhage: a prospective incident case-referent study. Stroke 2004;35:826-830.
18. Johansson I, Hallmans G, Wikman A, Biessy C, Riboli E, Kaaks R: Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort. Public Health Nutr 2002;5:487-496.
19. Meschia JF: Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research. Stroke 2002;33:2770-2774.
20. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
21. van der AD, Marx JJ, Grobbee DE, Kamphuis MH, Georgiou NA, van Kats-Renaud JH, Breuer W, Cabantchik ZI, Roest M, Voorbij HA, van der Schouw YT: Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation 2006;113:1942-1949.
22. Galan P, Hercberg S, Touitou Y: The activity of tissue enzymes in iron-deficient rat and man: an overview. Comp Biochem Physiol B 1984;77:647-653.
23. Zia E, Pessah-Rasmussen H, Khan FA, Norrving B, Janzon L, Berglund G, Engstrom G: Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. Cerebrovasc Dis 2006;21:18-25.
24. Oki I, Nakamura Y, Okamura T, Okayama A, Hayakawa T, Kita Y, Ueshima H: Body mass index and risk of stroke mortality among a random sample of Japanese adults: 19-year follow-up of NIPPON DATA80. Cerebrovasc Dis 2006;22:409-415.